Skin Substitute | Approved Indications |
| Affinity | Intended to be applied as an on-lay graft for acute and chronic wounds, including, but not limited to, neuropathic ulcers, venous stasis ulcers, pressure ulcers, burns, post-traumatic wounds and post-surgical wounds. |
| AlloPatch HD | Used as a wound care scaffold for the replacement of damaged or inadequate integumental tissue such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and vascular ulcers. |
| AlloSkin | Indicated for use in chronic wounds, dehisced wounds, diabetic foot ulcers, non/minimally exudating wounds, pressure ulcers, surgical wounds, and venous ulcers. |
| AlloSkin AC | Indicated for use in chronic wounds, dehisced wounds, diabetic foot ulcers, non/minimally exudating wounds, pressure ulcers, surgical wounds, and venous ulcers. |
| AlloSkin RT | Indicated for use in chronic wounds, dehisced wounds, diabetic foot ulcers, non/minimally exudating wounds, pressure ulcers, surgical wounds, and venous ulcers. |
AltiPly
| Indicated for homologous use as a biological barrier or wound cover, forming a protective cover for a variety of chronic wounds.
|
| Amnio Wound | Intended for use in the following conditions: neuropathic ulcers, venous stasis ulcers, post-traumatic wounds, pre-and post-surgical wounds, pressure ulcers, and diabetic wounds. |
AmnioAMP-MP
| Indications include application to partial and full-thickness chronic wounds (such as burns, diabetic wounds, venous wounds, arterial wounds, pressure wounds).
|
| AmnioArmor | Intended for use in chronic wounds. |
| AmnioBand Particulate | Intended for use in a variety of wounds: diabetic foot ulcers, venous leg ulcers, pressure ulcers, vascular ulcers, traumatic wounds, and surgical wounds. |
| AmnioBand Membrane or Guardian | Intended for interior or exterior wounds including use as a covering for the surgical site. Usage includes various wounds and ulcers and other soft tissue defects. |
| Amniobind | Intended for homologous use in the treatment of chronic wounds.
|
AmnioCore
| Intended for homologous use in the treatment of chronic wounds.
|
| AmnioExCel, AmnioExCel Plus, or BioDExCel | Used in the treatment of wounds including: diabetic ulcers, venous and arterial ulcers, pressure ulcers, traumatic injuries, surgical wounds, and burns. |
| AmnioMatrix or BioDMatrix | Used in the treatment of wounds including: diabetic ulcers, venous and arterial ulcers, pressure ulcers, traumatic injuries, surgical wounds, and burns. |
Amnio-Maxx
Amnio-Maxx Lite
| Indicated for chronic, non-healing wounds such as diabetic foot ulcers and venous leg ulcers or soft tissue defects.
|
Amnion Bio or Axobiomembrane
| Indicated for full and partial-thickness, chronic wounds and hard to heal wounds.
|
Amniorepair
| Indicated for homologous use as a biological barrier or wound cover, forming a protective cover for a variety of chronic wounds.
|
Amniotext
Amniotext Patch
| Intended for chronic non-healing wounds such as diabetic foot ulcers and venous leg ulcers.
|
AmnioWrap2
| Intended for the treatment of chronic, non-healing wounds, including lower extremity ulceration caused by diabetes, chronic venous disease, and other chronic conditions.
|
Amniply
| Used as a wound covering for chronic, non-healing wounds such as diabetic foot ulcers, venous leg ulcer, and pressure ulcers.
|
Apis
| Indicated in the management of wounds, including: full and partial thickness wounds, pressure ulcers (stages I-IV), venous stasis ulcers, diabetic ulcers, abrasions, surface wounds, traumatic wounds (healing by secondary intention), donor site wounds, and surgical wounds.
|
| Apligraf | Indicated for use with standard therapeutic compression for the treatment of non-infected partial and full-thickness skin ulcers due to venous insufficiency.
Indicated for use with standard diabetic foot ulcer care for the treatment of full-thickness neuropathic diabetic foot ulcers and which extend through the dermis but without tendon, muscle, capsule or bone exposure. |
Architect Extracellular Collagen Matrix
Architect Px Extracellular Collagen Matrix
Architect Fx Extracellular Collagen Matrix | Indicated for the local management of moderately to heavy exuding wounds, including: partial and full thickness wounds, draining wounds, pressure sores/ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, partial thickness burns, skin tears), surgical wounds (e.g., donor sites/grafts, post-laser surgery, post-Moh's surgery, podiatric wounds, dehisced surgical incisions). |
| Artacent AC | Indicated for use in partial- and full-thickness chronic wounds, such as, traumatic and complex wounds, burns, surgical and Moh's surgery sites, diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers. |
| Artacent AC Powder | Indicated for use in chronic wounds such as diabetic ulcers, pressure ulcers, venous stasis ulcers, and burns. |
Artacent Cord
| Intended for the treatment of chronic wounds such as diabetic ulcers, venous stasis ulcers, burns, and additional wounds that are refractory to more conservative care.
|
| Artacent Wound | Indicated for use as a wound cover on chronic wounds such as diabetic ulcers, pressure ulcers, venous stasis ulcers, and burns. |
Axolotl Ambient
Axolotl Cryo
| Chronic non-healing wounds.
|
Axolotl DualGraft
Axolotl Graft
| Chronic non-healing wounds.
|
Barrera SL or Barrera DL
| Serves as a wound cover or barrier to offer protection from the surrounding environment in wounds, including surgically created wounds.
|
BellaCell HD
| Indicated for use in chronic, non-healing ulcers.
|
| Bio-ConneKt Wound Matrix | Indicated for the local management of moderately to heavily exuding wounds, including: partial and full-thickness wounds, draining wounds, tunneling wounds, pressure sores/ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, partial thickness burns, skin tears), and surgical wounds (e.g., donor sites/grafts, post-laser surgery, post-Mohs' surgery, podiatric wounds, dehisced surgical incisions). |
| BioDFence | Usage includes allograft application to wounds including: traumatic injuries, burns, Moh's procedures or surgical wounds, diabetic ulcers, venous and arterial leg ulcers, pressure ulcers or cutaneous ulcers. |
| BioSkin | Intended to be used as a wound covering and is surgically applied to the skin in the treatment of chronic acute and surgical wounds. |
| BioSkin Flow | Intended to replace or supplement damaged or inadequate integument. For use in difficult to reach, irregularly shaped or tunneled wounds. |
| Biovance | Indicated for a broad range of wound types, including: Moh's surgery, burns, trauma, surgical, venous leg ulcers, diabetic ulcers, pressure ulcers, arterial ulcers. |
Biovance tri-layer or Biovance 3l
| Intended to be used as a cover or to protect from the surrounding environment in wound and surgical repair and reconstruction procedures.
|
BioWound
BioWound Plus
BioWound XPlus
| Intended for use as a wound covering, application to partial-and full-thickness, chronic wounds such as, traumatic and complex wounds, burns, surgical and Mohs surgery sites and diabetic, venous, arterial, pressure and other ulcers.
|
carePATCH
| Intended for the treatment of non-healing wounds and burn injuries
|
Celera Dual Layer
Celera Dual Membrane
| Intended to serve as a wound cover or skin substitute in individuals with cutaneous wounds.
|
| Cellesta Amniotic Membrane | Indicated for: diabetic ulcers, pressure ulcers, surgical wounds, venous ulcers. |
Cellesta Cord
| Intended for use as a regenerative wound covering for the treatment of chronic wounds.
|
| Cellesta Flowable Amnion | Indicated for: diabetic ulcers, pressure ulcers, surgical wounds, venous ulcers. |
| Clarix Flo | Used in the treatment of partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers. |
Cocoon Dual-Layer and Single-Layer Membrane
| Intended for full and partial-thickness, chronic wounds.
|
Cogenex Amniotic Membrane
| Intended for homologous use for chronic wound repair.
|
Cogenex Flowable Amnion
| Intended for treatment of chronic, non-healing deep dermal wounds, irregularly-shaped, crevassing and tunneling wounds, augmentation of deficient/inadequate soft tissue, and other complex wound cases where a patch form of amniotic membrane may not provide complete wound coverage. |
| Coll-e-derm | Indicated for use in chronic, non-infected, full-or partial thickness diabetic or venous insufficiency ulcers. |
Complete FT
Complete SL
| Intended to be used as a barrier and provides protective coverage from the surrounding environment to acute and chronic wounds.
|
CoreText
| To be used for wounds and tissue defects.
|
Corplex
| Intended to be used as a wound covering or barrier membrane over chronic wounds.
|
Corplex P
| Indicated for use in chronic, non-healing wounds.
|
Cryo-Cord
| Used for chronic, non-healing wounds.
|
| Cygnus | Indicated for use in chronic wounds and burns. |
Cygnus Dual
| Intended for use as a tissue barrier or wound covering
|
| Cytal Wound Matrix | Intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post- Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, skin tears), and draining wounds. |
Derm-Maxx
| Used for integumentary augmentation and serve as a covering for wounds and skin defects.
|
Dermabind SL
| Intended includes the management of wounds, such as, partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds, trauma wounds, and draining wounds.
|
| DermACELL | Indications for use include: arterial ulcers, chronic wounds, deep wounds, diabetic foot ulcers, and pressure ulcers. |
DermACELL AWM
DermACELL AWM Porous
| Indicated for use in chronic non-healing wounds such as diabetic foot ulcers, venous stasis ulcers, arterial ulcers, pressure ulcers, dehisced surgical wounds, traumatic burns.
|
Dermacyte
| Indicated use in the treatment of non-infected partial thickness skin ulcers (diabetic foot ulcer, venous stasis ulcer, decubitus ulcer) greater than 1-month duration and which have not adequately responded to conventional therapy, or as clinically indicated.
|
| Dermagraft | Indicated for use in the treatment of full-thickness diabetic foot ulcers, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. |
| DermaPure | Used as a covering for difficult or hard to heal, acute and chronic wounds. |
| DermaSpan Acellular Dermal Matrix | Intended use is for the repair or replacement of damaged or inadequate integumental tissue (wound coverage). |
| Dermavest | Indicated for the management of wounds that include: partial and full thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears), drainage wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric). |
Dual Layer Impax Membrane
| Intended to serve as a barrier or cover for chronic wounds.
|
Enverse
| To be used as a wound covering or barrier membrane, over chronic and acute wounds, including dermal ulcers or defects.
|
| EpiCord | Indicated for use to replace or supplement damaged or inadequate integumental tissue. |
Epieffect
| Intended for use as a barrier, to provide a protective environment in acute and chronic wounds.
|
| EpiFix | Used in the treatment of partial and full-thickness wounds including, but not limited to: diabetic foot ulcers, venous leg ulcers, arterial ulcers, pressure ulcers, and inflammatory ulcers. |
| EpiFix, Injectable | Usage includes injectable applications for neuropathic ulcers, venous stasis ulcers, post traumatic ulcers, post-surgical ulcers and pressure ulcers. |
Esano AAA
Esano AC
Esano ACA
| Intended for use as a cover or barrier for acute and chronic wounds and to provide protective coverage from the surrounding environment for acute and chronic wounds
|
| Excellagen | Indicated for the management of wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/ undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears) and draining wounds. |
| E-Z Derm Biosynthetic Wound Dressing | Indicated for use on partial-thickness skin loss, donor sites, skin ulcerations and abrasions. Other applications may include temporary covering for full-thickness skin loss. |
| FlowerDerm | Indicated for use on chronic, non-infected, full thickness diabetic lower extremity ulcers, and chronic, non-infected, partial or full-thickness diabetic lower extremity skin ulcers due to venous insufficiency which have not adequately responded following conventional ulcer therapy. |
| FlowerFlo (FlowerAmnioFlow) | Indicated for use on chronic, non-infected, full thickness diabetic lower extremity ulcers, and chronic, non-infected, partial or full-thickness diabetic lower extremity skin ulcers due to venous insufficiency which have not adequately responded following conventional ulcer therapy. |
| FlowerPatch (FlowerAmnioPatch) | Indicated for use on chronic, non-infected, full thickness diabetic lower extremity ulcers, and chronic, non-infected, partial or full-thickness diabetic lower extremity skin ulcers due to venous insufficiency which have not adequately responded following conventional ulcer therapy. |
Fluid Flow
Fluid GF
| Indicated for chronic non-healing wounds.
|
| GammaGraft | Indications for use include: venous stasis ulcers, diabetic foot ulcers, full thickness ulcers, Moh's surgery sites, skin graft donor sites, partial thickness wounds, and areas of dermabrasion. |
| Geistlich Derma-Gide | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, skin tears, second-degree burns), surgical wounds (e.g., donor sites/grafts, post-Mohs' surgery, post laser surgery, podiatric, wound dehiscence). |
| Genesis Amniotic Membrane | Indicated for use on chronic wounds and skin ulcers. |
| Grafix Core | Indications for use include: diabetic foot ulcers, burns, deep tunneling wounds, pressure ulcers, pyoderma gangrenosum, surgical dehiscence, surgical incisions, and venous leg ulcers. |
| GrafixPL Core | Indications for use include: diabetic foot ulcers, burns, deep tunneling wounds, pressure ulcers, pyoderma gangrenosum, surgical dehiscence, surgical incisions, and venous leg ulcers. |
| Grafix Prime | Indications for use include: diabetic foot ulcers, burns, deep tunneling wounds, pressure ulcers, pyoderma gangrenosum, surgical dehiscence, surgical incisions, and venous leg ulcers. |
| GrafixPL Prime | Indications for use include: diabetic foot ulcers, burns, arterial ulcers, deep tunneling wounds, pressure ulcers, pyoderma gangrenosum, surgical dehiscence, trauma, surgical incisions, and venous leg ulcers. |
| Graftjacket Xpress Flowable Soft Tissue Scaffold | For repair or replacement of damaged or inadequate integumental tissue, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or for other homologous uses of human integument. |
| Graftjacket Regenerative Tissue Matrix (RTM) | For repair or replacement of damaged or inadequate integumental tissue, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, or for other homologous uses of human integument. |
| Helicoll | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, skin tears, second-degree burns), surgical wounds (e.g., donor sites/grafts, post-Mohs' surgery, post laser surgery, podiatric, wound dehiscence). |
| hMatrix Acellular Dermis | Indicated for use to replace damaged or inadequate integumental tissue. |
Human health factor 10 amniotic patch (HHF10-P)
| Used for chronic, non-healing wounds.
|
Hyalomatrix
Hyalomatrix PA | Indicated for the management of wounds including: partial and full-thickness wounds, second-degree burns, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undetermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, skin tears), and draining wounds. |
| Integra Bilayer Matrix Wound Dressing (BMWD) | Indicated for the management of wounds including: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. |
Innovaburn or Innovamatrix XL
| Intended for use in the management of wounds, including: partialand full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor site/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds, (abrasions, lacerations, and skin tears), partial-thickness second degree burns, and draining wounds.
|
Innovamatrix AC
| Indicated for the management of wounds include the following: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears), and draining wounds.
|
Innovamatrix FS
| Indicated for the management of wounds include the following: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears), and draining wounds.
|
Innovamatrix PD
| Intended for use in the management of wounds, including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor site/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds, (abrasions, lacerations, and skin tears), draining wounds, and partial-thickness second-degree burns.
|
Integra Dermal Regeneration Template (DRT)
Integra Omnigraft Dermal Regeneration Matrix | Indicated for the treatment of partial and full-thickness neuropathic diabetic foot ulcers that are greater than six weeks in duration, with no capsule, tendon or bone exposed, when used in conjunction with standard diabetic ulcer care. |
| Integra Flowable Wound Matrix | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds, (e.g., donor sites/grafts, post-Moh's surgery, post laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears) and draining wounds. |
| Integra Matrix Wound Dressing | Indicated for the management of wounds including: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. |
| Integra Meshed Bilayer Wound Dressing | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (e.g., donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, and skin tears) and draining wounds. |
| Integuply | Typically used in conjunction with a chronic wound care management regimen for the treatment of diabetic ulcers, charcot foot ulcers, venous ulcers, trauma wounds, pressure ulcers, partial and full thickness wounds, and surgical wounds. |
| Interfyl | Intended for use as the replacement or supplementation of damaged or inadequate integumental. Indications for include treatment of deep dermal wounds, irregularly-shaped and tunneling wounds, augmentation of deficient/inadequate soft tissue, and the repair of small surgical defects. |
| Keramatrix | Indicated for the following types of chronic wounds: pressure ulcers, venous stasis ulcers,
ulcers caused by mixed vascular etiologies, diabetic ulcers, and donor sites and grafts. |
Kerasorb
| Indicated for the following types of chronic wounds: pressure ulcers (stages I-IV), venous stasis ulcers, ulcers caused by mixed vascular etiologies, diabetic ulcers, and donor sites and grafts.
|
| Kerecis Omega3 Wound | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears), surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), and draining wounds. |
Kerecis Omega3 Marigen Shield
| Indicated for the management of wounds such as partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (abrasions, lacerations, partial-thickness burns, skin tears), surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), draining wounds.
|
| Keroxx Flowable Wound Matrix | Intended for use on chronic wounds, surgical wounds, donor sites/grafts, diabetic ulcers, chronic ulcers of mixed vascular etiologies, venous stasis ulcers, pressure ulcers (stages I-IV), partial & full thickness wounds, and donor sites/grafts. |
| Matrion | Intended to be used as a wound covering for chronic wounds. |
| MatriStem MicroMatrix | Intended for the management of topical wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, and skin tears), and draining wounds. |
| Matrix HD | Used in diabetic ulcers, Charcot foot ulcers, venous ulcers, trauma wounds, pressure sores/ulcers, partial and full thickness wounds and surgical wounds. |
| Mediskin | Intended for the management of wounds that include: partial and full thickness wounds, pressure ulcers, diabetic ulcers, venous ulcers chronic vascular ulcers, second-degree burns, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, skin tears), tunneled/undermined wounds, and draining wounds. |
Membrane Graft
Membrane Wrap
| Indicated for non-healing chronic wounds such as diabetic, venous, mixed, venous-arterial, and pressure ulcers.
|
| MemoDerm Acellular Dermal Matrix | Intended use is for chronic diabetic foot ulcers. |
Mlg-complete
| For the management of wounds and burn injuries.
|
Miro3d
| Intended for use as protective environment for wound management.
|
| Miroderm | Indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, tunneled/undermined wounds, trauma wounds (abrasions, lacerations, second-degree burns, skin tears), drainage wounds, and surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence). |
Mirragen Advanced Wound Matrix
| Indicated for chronic non-healing wounds.
|
Myriad Matrix
| For the management of acute and hard-to-heal wounds, including partial- and full-thickness wounds; pressure ulcers; venous leg ulcers; diabetic foot ulcers; chronic vascular ulcers; tunnelled/ undermined wounds; surgical wounds (donor sites, grafts, post Mohs surgery, post-laser surgery, podiatric wounds and wound dehiscence); traumatic wounds (abrasions, lacerations, second-degree burns and skin tears); draining wounds.
|
Neomatrix
| Intended for use in the management of wounds, including partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor site/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds, (abrasions, lacerations, second-degree burns and skin tears), and draining wounds.
|
| NeoPatch | Used in the treatment of lower extremity ulcerations caused by diabetes, chronic venous disease, and other chronic conditions. |
Neostim tl
Neostim membrane
Neostim dl
| Intended for use as a barrier or provides a protective coverage from the surrounding environment for acute and chronic wounds such as; partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds and trauma wounds.
|
| Neox 100 Wound Matrix | Used in the treatment of partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers. |
| Neox Cord 1k Wound Matrix | Used in the treatment of partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers. |
| Neox Cord RT | Used in the treatment of partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers. |
| Neox Flo | Used in the treatment of partial- and full-thickness wounds including: diabetic foot ulcers, venous leg ulcers, arterial ulcers, and pressure ulcers. |
| Novachor | Intended to be applied as a graft for chronic wounds, including, but not limited to, neuropathic ulcers, venous stasis ulcers, pressure ulcers, burns, post-traumatic wounds and post-surgical wounds. |
Novafix
Novafix DL
| Indicated for use in the management of wounds, including: partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites, post-laser surgery, post-Mohs surgery, podiatric wounds and wound dehiscence), trauma wounds (abrasions, lacerations, partial thickness burns, skin tears), and draining wounds.
|
| NuShield | Intended to be applied as an on-lay graft for acute and chronic wounds, including, but not limited to, neuropathic ulcers, venous stasis ulcers, pressure ulcers, burns, post-traumatic wounds and post-surgical wounds. |
| Oasis Burn Matrix | Intended use is for the management of second-degree burns and donor sites. |
| Oasis Ultra Tri-Layer Wound Matrix | Indicated for the management of: partial and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, tunneled/undermined wounds, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears), surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), and draining wounds. |
| Oasis Wound Matrix | Intended use is for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, and skin tears), and draining wounds. |
Omeza Collagen Matrix
| Indicated for the management of wounds including: partial and full‐thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post‐Moh’s surgery, post‐laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, superficial partial thickness burns, skin tears) and draining wounds.
|
Orion
| Intended to serve as a barrier or cover for acute and chronic wounds and for use as a barrier to protect wounds from the surrounding environment.
|
PalinGen Flow
PalinGen ProMatrX ACF
PalinGen SportFlow | Used in the treatment of chronic wounds that are most prevalent in older populations, particularly in patients with Type I diabetes. |
PalinGen Membrane
PalinGen XPlus Membrane | Used in the treatment of chronic wounds, including venous leg ulcers, diabetic ulcers, and pressure ulcers. |
Permeaderm B
Permeaderm C
| Indicated for donor sites, partial thickness burns.
Indicated for the management of chronic wounds that include: partial and full thickness wounds, pressure sores, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s, post-laser surgery, podiatric, wound dehiscence, trauma wounds (abrasions, lacerations, second-degree burns, and skin tears), and draining wounds.
|
Phoenix Wound Matrix
| For the management of acute and chronic wounds, and burns.
|
| Plurivest | Indicated for the management of wounds that include: partial and full thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears), drainage wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric). |
| PriMatrix Dermal Repair Scaffold | Intended for the management of wounds that include: partial and full thickness wounds, pressure ulcers, diabetic ulcers, venous ulcers, second-degree burns, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, and skin tears), tunneled/undermined wounds, and draining wounds. |
Procenta
| Indicated to treat chronic non-healing wounds, such as venous stasis and diabetic foot ulcers.
|
ProgenaMatrix
| Indicated for dry and exuding partial and full thickness wounds such as pressure (stage I-IV) and venous stasis ulcers, ulcers caused by mixed vascular etiologies, diabetic ulcers, donor sites and grafts, first and second-degree burns, superficial injuries, cuts, abrasions and surgical wounds.
|
ProText
| To be used for wounds and tissue defects.
|
| PuraPly (formerly called Fortaderm Wound Dressing) | Indicated for the management of: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears) and draining wounds. |
| PuraPly Antimicrobial Wound Dressing (formerly called Fortaderm Antimicrobial Wound Dressing) | Indicated for the management of: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears) and draining wounds. |
| PuraPly Antimicrobial XT Wound Matrix | Indicated for the management of: partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, second-degree burns, skin tears) and draining wounds. |
REGUaRD
| Intended to be used in chronic, non-healing wounds and burns.
|
Relese
| Intended for use as a selective barrier and to protect wounds from the surrounding environment for chronic and acute wounds including dermal ulcers and other defects.
|
Resolve Matrix
| Indicated for the management of topical wounds, including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds, trauma wounds, draining wounds, and tunneled or undermined wounds. |
| Restorigin AFT | Intended to be used in chronic, non-healing wounds and burns. |
| Restorigin Amnion Patch | Intended to be used in chronic, non-healing wounds and burns. |
Restrata
| Indicated for wound management and includes partial and full thickness wounds, pressure sores, venous, diabetic and chronic vascular ulcers, wounds with tunneling or undermining, surgical (e.g. donor site/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, wound dehiscence) trauma and draining wounds.
|
| Revita | Intended to be used as a wound covering for chronic wounds, including dermal ulcers or defects. |
| Revitalon | Indicated for the management of wounds including: diabetic ulcers and venous ulcers. |
Signature Apatch
| Indicated for use in acute or chronic wounds, including but not limited to venous leg ulcers, pressure ulcers, diabetic foot ulcers, surgical wounds, burns, and wounds with exposed tendon, muscle, and/or bone.
|
| SkinTE | Intended to be used as a wound covering for chronic wounds. |
Stravix
Stravix PL
| Indicated for use in chronic non-healing wounds such as diabetic ulcers, pressure ulcers, surgical wounds, and venous ulcers.
|
Supra SDRM
| For the management of epidermal and dermal wounds, including those caused by burns, pressure ulcers, and venous ulcers.
|
Suprathel
| Used for epidermal and dermal wounds, such as split skin graft donor sites and partial thickness burns. Suprathel may also be used for partial and full thickness wounds.
|
SureDerm Acellular Dermal Matrix
| Indicated for use in chronic, non-healing ulcers.
|
SurgiCORD
| Intended for use in chronic, non-healing wounds such as neuropathic ulcers, venous stasis ulcers, post-traumatic and pressure ulcers.
|
| surgiGRAFT | Intended for use in the following conditions: neuropathic ulcers, venous stasis ulcers, post-traumatic wounds, pre- and post- surgical wounds and pressure ulcers, diabetic wounds, anf burn wounds. |
SurgiGRAFT-DUAL
| Intended for use to repair or replace dermal tissue, including in the treatment of chronic, non-healing wounds including neuropathic ulcers, post-traumatic and pressure ulcers.
|
SurGraft
| Intended for the treatment of non-healing chronic wounds, including but not limited to, chronic, non-infected, diabetic foot ulcers, chronic, non-infected, partial or full-thickness diabetic foot skin ulcers (due to venous insufficiency), pressure ulcer, surgical wounds and burns which have not adequately responded to conventional therapy.
|
SurGraft FT
| Intended to act as a barrier and provide protective coverage from the surrounding environment for acute and chronic wounds such as; partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds trauma wounds and draining wounds.
|
SurGraft TL
| Intended for the treatment of chronic wounds such as partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (e.g., donor site/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, wound dehiscence), trauma wounds (e.g., abrasions, lacerations, partial thickness burns, skin tears), and draining wounds.
|
SurGraft XT
| Intended to act as a barrier and provide protective coverage from the surrounding environment for acute and chronic wounds such as; partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds trauma wounds and draining wounds.
|
Symphony
| Chronic, non-healing diabetic foot ulcers and venous leg ulcers.
|
Tag
| Intended for use in chronic, non-healing wounds.
|
| Talymed | Indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular etiologies, full thickness and partial thickness wounds, second degree burns, surgical wounds (e.g., donor sites/grafts, post-Moh's surgery, post-laser surgery), abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers, and dehisced surgical wounds. |
| TenSIX Acellular Dermal Matrix | Chronic diabetic foot ulcers |
Theragenesis
| Intended for the treatment of patients with chronic and traumatic wounds including but not limited to diabetic foot ulcers, venous leg ulcers, burns, and other chronic and traumatic wounds and tissue deficits.
|
| TheraSkin | Can be used to replace or repair skin over any wound, including those with exposed muscle, tendon, bone and joint capsule. This includes, but is not limited to, diabetic foot ulcers, venous leg ulcers, arterial ulcers, pressure sores, dehisced surgical wounds, and wounds that might otherwise require an autograft. |
Therion
| Chronic diabetic foot ulcers.
|
| TranZgraft Acellular Dermal Matrix | Intended use is for ulcer repair. |
| TruSkin | Indicated for the management of wounds including: diabetic foot ulcers, venous leg ulcers, pressure ulcers, dehisced surgical wounds, traumatic burns, and radiation burns. |
Vendaje
| Intended use is for chronic and acute pressure sores/ulcers related to disease processes, partial thickness burns, draining wounds, post-surgical wounds, and trauma wounds such as abrasions and skin tears.
|
VIM Amniotic Membrane
| Intended use as a wound covering.
|
| WoundEx | Intended to be used as a wound covering and is surgically applied to the skin in the treatment of
chronic acute and surgical wounds. |
| WoundEx Flow | Intended to replace or supplement damaged or inadequate integument. For use in difficult to reach, irregularly shaped or tunneled wounds. |
WoundFix
WoundFix Plus
WoundFix XPlus Membrane
| Intended for use as a wound covering, application to partial-and full-thickness, chronic wounds such as, traumatic and complex wounds, burns, surgical and Mohs surgery sites and diabetic, venous, arterial, pressure and other ulcers.
|
Woundplus Membrane
e-graft
| Intended for use as a barrier, wrap or cover for acute and chronic wounds.
|
Xcell Amino Matrix
| Intended for use as a barrier and provides protective coverage from the surrounding environment for acute and chronic wounds such as partial and full thickness wounds, pressure sores/ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds, trauma wounds and draining wounds.
|
XCellerate
| Used for the treatment of non-healing wounds and burn injuries.
|
XCellistem
| Indicated for wound management of partial and full thickness wounds, pressure sores, venous and diabetic ulcers, wounds with tunneling or undermining, surgical (e.g. donor site/grafts, post-laser surgery, post-Mohs surgery, podiatric wounds, wound dehiscence), and trauma wounds.
|
| XWRAP | Indicated for chronic wounds, diabetic ulcers, pressure ulcers, and venous ulcers. |
Zenith Amniotic Membrane
| Intended for the treatment of chronic non-healing wounds including but not limited to noninfected partial or full-thickness diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burn injuries which have not responded to conventional therapy.
|
